financetom
Business
financetom
/
Business
/
Ukraine's sovereign dollar bonds jump after IMF signs off on $880 mln tranche
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Ukraine's sovereign dollar bonds jump after IMF signs off on $880 mln tranche
Mar 22, 2024 4:22 AM

By Jorgelina do Rosario

LONDON, March 22 (Reuters) - Ukraine's sovereign dollar

bonds jump on Friday after the International Monetary Fund

signed off on a $880 million tranche of the country's $15.6

billion programme.

Adding to the momentum for bonds was an announcement on

Thursday that the European Union could use proceeds from frozen

Russian assets to help Ukraine within a few months under a plan

that includes buying arms for Kyiv.

The 2028 dollar-denominated bond saw the biggest gains, up

2.4 cents to 34.06 cents at 1048 GMT, while longer maturities

were up as much as 1.7 cents on the dollar.

"Moving forward with specific proposals to put to use the

frozen Russia assets is positive, after months of talk about it,

although we need to see the details," said Stuart Culverhouse,

chief economist at London-based research firm Tellimer.

The IMF approval was largely expected, Culverhouse added, so

"this may have already been discounted to some extent".

The latest IMF review brings the Fund's disbursements so far

to $5.4 billion.

Upcoming talks with bondholders for a debt rework on

Ukraine's private debt, and a report on a U.S. proposal to the

Group of Seven on a special purpose vehicle to issue bonds

backed by profits from frozen Russian assets, are other among

"multiple factors" that explain why the bonds are rising, said

Viktor Szabo, portfolio manager at Abrdn ( SLFPF ) in London.

"And maybe also the fact that Ukraine has underperformed the

very high yield complex this month," he added.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Stallion Uranium Commenced Drilling On Appaloosa Uranium Target
Stallion Uranium Commenced Drilling On Appaloosa Uranium Target
Mar 6, 2024
01:17 PM EST, 03/06/2024 (MT Newswires) -- Stallion Uranium Corp. ( STLNF ) announced Wednesday that it has begun drilling on its high priority Appaloosa Target as part the company's maiden drill program on its Coffer Project in the prolific Southwestern Athabasca Basin in Saskatchewan The objective of the drill program is the discovery of uranium mineralization associated with conductive...
Update: Albemarle Rises After Pricing of Upsized Offering of Depositary Shares
Update: Albemarle Rises After Pricing of Upsized Offering of Depositary Shares
Mar 6, 2024
01:21 PM EST, 03/06/2024 (MT Newswires) -- (Updates to add stock move in the headline and the first paragraph.) Albemarle (ALB) shares rose more than 8% in recent Wednesday trading after the company priced its underwritten public offering of 40 million depositary shares at $50 apiece, upsized from $1.75 billion previously. Each depositary share represents a 1/20th interest in a...
Spanish Healthcare Firm Grifols Hit With New Gotham City's Short Report, Faces Questions Regarding Transparency, Integrity, Ethical Conduct
Spanish Healthcare Firm Grifols Hit With New Gotham City's Short Report, Faces Questions Regarding Transparency, Integrity, Ethical Conduct
Mar 6, 2024
Grifols ( GRFS ) SA shares are down on Wednesday following the publication of a new report by Gotham City Research questioning the company’s “transparency, integrity and ethical conduct.” Grifols ( GRFS ) had previously denied Gotham City’s accusations, as per its February SEC filing, saying it had already replied to all of the questions raised in the latter’s reports. Grifols ( GRFS ) claimed...
Update: DexCom Shares Rise After Prescription-Free Glucose Biosensor Wins FDA Clearance
Update: DexCom Shares Rise After Prescription-Free Glucose Biosensor Wins FDA Clearance
Mar 6, 2024
01:18 PM EST, 03/06/2024 (MT Newswires) -- (Updates with the latest stock movement in the headline and first paragraph.) DexCom's ( DXCM ) shares were up more than 9% in recent Wednesday trading after the company's prescription-free glucose biosensor, Stelo by Dexcom ( DXCM ), won clearance from the US Food and Drug Administration on Tuesday. Stelo, designed for individuals...
Copyright 2023-2026 - www.financetom.com All Rights Reserved